191 related articles for article (PubMed ID: 12574850)
1. Borderline serous cystadenocarcinoma with coexistent angiosarcoma: an unusual form of ovarian carcinosarcoma.
Pillay K; Essa AS; Chetty R
Int J Surg Pathol; 2001 Oct; 9(4):317-21. PubMed ID: 12574850
[TBL] [Abstract][Full Text] [Related]
2. Carcinosarcoma of ovary with its various immunohistochemical expression: Report of a rare case.
Dasgupta S; Bose D; Bhattacharyya NK; Biswas PK
J Cancer Res Ther; 2015; 11(4):1022. PubMed ID: 26881579
[TBL] [Abstract][Full Text] [Related]
3. Ovarian carcinosarcoma associated with bilateral tubal intraepithelial carcinoma: a case report.
Brustmann H
Int J Gynecol Pathol; 2013 Jul; 32(4):384-9. PubMed ID: 23722511
[TBL] [Abstract][Full Text] [Related]
4. Serous ovarian carcinoma recurring as a heterologous carcinosarcoma.
Ferrandina G; Carbone A; Zannoni GF; Martinelli E; Testa AC; Gallotta V; De Ninno M; Scambia G
J Obstet Gynaecol Res; 2007 Feb; 33(1):95-9. PubMed ID: 17212675
[TBL] [Abstract][Full Text] [Related]
5. Serous papillary adenocarcinoma and adult granulosa cell tumor in the same ovary. An unusual case.
Ozbey C; Erdogan G; Pestereli HE; Simsek T; Karaveli S
APMIS; 2005 Oct; 113(10):713-5. PubMed ID: 16309432
[TBL] [Abstract][Full Text] [Related]
6. Carcinosarcoma arising from high-grade serous carcinoma of the ovary without estrogen receptor, WT-1, and PAX8 immunoreactivity.
Harada N; Nobuhara I; Haruta N; Higashiura Y; Fujii H; Yamao K; Shimada K
Taiwan J Obstet Gynecol; 2022 Jan; 61(1):110-114. PubMed ID: 35181017
[TBL] [Abstract][Full Text] [Related]
7. Serous papillary cystadenocarcinoma arising from autografted ovary of the abdominal wall.
Gong W; Cheng H; Yan Q; Huang G; Luo P; Wang Z
Int J Surg Pathol; 2010 Oct; 18(5):398-400. PubMed ID: 19147508
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a human carcinosarcoma cell line of the ovary established after in vivo change of histologic differentiation.
Möbus VJ; Gerharz CD; Weikel W; Merk O; Dreher L; Kreienberg R; Moll R
Gynecol Oncol; 2001 Dec; 83(3):523-32. PubMed ID: 11733966
[TBL] [Abstract][Full Text] [Related]
9. Endometrioid adenocarcinoma of the ovary mimicking serous borderline tumor: report of a series of cases.
Mansor S; McCluggage WG
Int J Gynecol Pathol; 2014 Sep; 33(5):470-6. PubMed ID: 25083962
[TBL] [Abstract][Full Text] [Related]
10. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
[TBL] [Abstract][Full Text] [Related]
11. Ovarian low-grade serous carcinoma involving the cervix mimicking a cervical primary.
Malpica A; Deavers MT
Int J Gynecol Pathol; 2011 Nov; 30(6):613-9. PubMed ID: 21979600
[TBL] [Abstract][Full Text] [Related]
12. Carcinosarcoma of the ovary compared to papillary serous ovarian carcinoma: a SEER analysis.
Rauh-Hain JA; Diver EJ; Clemmer JT; Bradford LS; Clark RM; Growdon WB; Goodman AK; Boruta DM; Schorge JO; del Carmen MG
Gynecol Oncol; 2013 Oct; 131(1):46-51. PubMed ID: 23906658
[TBL] [Abstract][Full Text] [Related]
13. Malignant melanoma arising in an ovarian carcinosarcoma: case report and review of the literature.
Roma AA; Malpica A; Deavers MT
Int J Gynecol Pathol; 2011 Mar; 30(2):158-62. PubMed ID: 21293284
[TBL] [Abstract][Full Text] [Related]
14. Progressive loss of selenium-binding protein 1 expression correlates with increasing epithelial proliferation and papillary complexity in ovarian serous borderline tumor and low-grade serous carcinoma.
Zhang C; Wang YE; Zhang P; Liu F; Sung CJ; Steinhoff MM; Quddus MR; Lawrence WD
Hum Pathol; 2010 Feb; 41(2):255-61. PubMed ID: 19896693
[TBL] [Abstract][Full Text] [Related]
15. Cell polarity reversal in ovarian low-grade serous carcinomas and micropapillary serous borderline tumours: immunohistochemical observations.
Hui Y; Ou JJ; Sung CJ; Lawrence WD; Quddus MR
Histopathology; 2016 Nov; 69(5):892-894. PubMed ID: 27271798
[No Abstract] [Full Text] [Related]
16. Nanog is highly expressed in ovarian serous cystadenocarcinoma and correlated with clinical stage and pathological grade.
Pan Y; Jiao J; Zhou C; Cheng Q; Hu Y; Chen H
Pathobiology; 2010; 77(6):283-8. PubMed ID: 21266826
[TBL] [Abstract][Full Text] [Related]
17. CD34 immunohistochemistry in female genital tract carcinosarcoma (malignant mixed müllerian tumors) supports a dominant role of the carcinomatous component.
Costa MJ; Guinee D
Appl Immunohistochem Mol Morphol; 2000 Dec; 8(4):293-9. PubMed ID: 11127921
[TBL] [Abstract][Full Text] [Related]
18. Mixed angiosarcoma, clear cell adenocarcinoma and mature teratoma elements in an ovarian tumor: a case report and literature review.
Takahashi H; Chaopotong P; Kajita S; Hashimura M; Yamazaki H; Saegusa M
Pathol Int; 2012 Aug; 62(8):538-42. PubMed ID: 22827762
[TBL] [Abstract][Full Text] [Related]
19. Low-grade ovarian serous neoplasms (low-grade serous carcinoma and serous borderline tumor) associated with high-grade serous carcinoma or undifferentiated carcinoma: report of a series of cases of an unusual phenomenon.
Boyd C; McCluggage WG
Am J Surg Pathol; 2012 Mar; 36(3):368-75. PubMed ID: 22082603
[TBL] [Abstract][Full Text] [Related]
20. Serous psammocarcinoma of the ovary: a case report and review of literature.
Giordano G; Gnetti L; Milione M; Piccolo D; Soliani P
Gynecol Oncol; 2005 Jan; 96(1):259-62. PubMed ID: 15589614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
